You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Myocet

Showing 1 - 25 of 38
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Worldwide (Liposomal doxorubicin HCl, Cyclophosphamide, Trastuzumab)

Completed
  • Breast Cancer
  • Liposomal doxorubicin hydrochloride
  • +4 more
  • Kufstein, Austria
  • +21 more
Jun 21, 2022

Platinum-resistant Ovarian Cancer, Fallopian Tube Cancer, Primary Peritoneal Cancer Trial in Canada, United States (Nemvaleukin

Recruiting
  • Platinum-resistant Ovarian Cancer
  • +2 more
  • Nemvaleukin and Pembrolizumab Combination
  • +6 more
  • Ventura, California
  • +7 more
Aug 5, 2022

Breast Cancer, Triple Negative Breast Cancer Trial in United States (Carboplatin, Paclitaxel, Doxorubicin)

Active, not recruiting
  • Breast Cancer
  • Triple Negative Breast Cancer
  • Rockford, Illinois
  • +5 more
Mar 29, 2021

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast, Metastatic Breast Cancer Trial in Amsterdam (Paclitaxel,

Completed
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Metastatic Breast Cancer
  • Paclitaxel, Bevacizumab, liposomal doxorubicin, Capecitabine
  • Amsterdam, Netherlands
    BOOG Study Center
Jan 16, 2020

Acute Lymphoblastic Leukemia, Pediatric Trial in Worldwide (Blinatumomab, Bortezomib, Cyclophosphamide)

Recruiting
  • Acute Lymphoblastic Leukemia, Pediatric
  • Sydney, Australia
  • +114 more
Nov 1, 2022

Early Primary Breast Cancer Trial in Moenchengladbach, Munich (Myocet, Cyclophosphamide, Paclitaxel)

Unknown status
  • Early Primary Breast Cancer
  • Myocet
  • +2 more
  • Moenchengladbach, Germany
  • +1 more
Jul 20, 2019

HER-2 Positive Breast Cancer Trial in Italy (Liposomal doxorubicin, Docetaxel, Trastuzumab)

Completed
  • HER-2 Positive Breast Cancer
  • Liposomal doxorubicin
  • +3 more
  • Meldola, FC, Italy
  • +8 more
Apr 20, 2020

Breast Cancer Trial in Belgium, France (HORMONOTHERAPY, CHEMOTHERAPY then HORMONOTHERAPY)

Active, not recruiting
  • Breast Cancer
  • Arlon, Belgium
  • +83 more
Apr 1, 2022

Lymphoma Trial in Spain (RCOMP, RCHOP)

Unknown status
  • Lymphoma
  • Vitoria, Alava, Spain
  • +13 more
Jan 8, 2020

Advanced Solid Tumors Trial in Switzerland (TLD-1, Caelyx)

Recruiting
  • Advanced Solid Tumors
  • Bellinzona, Switzerland
  • +3 more
Dec 24, 2021

Breast Cancer Trial in Spain (Myocet, Taxotere, Herceptin)

Completed
  • Breast Cancer
  • Myocet
  • +2 more
  • Alcoy, Alicante, Spain
  • +15 more
Jul 24, 2018

Ovarian Cancer Trial in France (carboplatin and liposomal doxorubicin)

Completed
  • Ovarian Cancer
  • carboplatin and liposomal doxorubicin
  • Agen, France
  • +41 more
May 30, 2018

Breast Cancer Trial in Spain (Liposomal Doxorubicin)

Completed
  • Breast Cancer
  • Liposomal Doxorubicin
  • Barcelona, Spain
  • +18 more
Oct 31, 2017

Tubular Breast Cancer Stage II, Tubular Breast Cancer Stage III, Mucinous Breast Cancer Stage II Trial in Heidelberg

Completed
  • Tubular Breast Cancer Stage II
  • +6 more
  • non-pegylated liposomal doxorubicin
  • +7 more
  • Heidelberg, Baden-Württemberg, Germany
    NTC
Jul 10, 2017

Malignant Glioma Trial in France (Doxorubicin)

Completed
  • Malignant Glioma
  • Lille, France
  • +6 more
Aug 5, 2016

Breast Cancer Trial in Berlin (Myocet (Non-pegylated liposomal doxorubicin (NPLD)), Paclitaxel, Lapatinib (GW572016, Tykerb))

Completed
  • Breast Cancer
  • Myocet (Non-pegylated liposomal doxorubicin (NPLD))
  • +2 more
  • Berlin, Germany
    Sana Klinikum Lichtenberg
Nov 1, 2016

Human Epidermal Growth Factor 2 Negative Carcinoma of Breast Trial in Italy (Metformin + Myocet + Cyclophosphamide, Myocet +

Completed
  • Human Epidermal Growth Factor 2 Negative Carcinoma of Breast
  • Metformin + Myocet + Cyclophosphamide
  • Myocet + Cyclophosphamide
  • Cesena, FC, Italy
  • +24 more
Dec 31, 2015

Hodgkin Lymphoma Trial in Italy (MBVD (Myocet+BVD))

Completed
  • Hodgkin Lymphoma
  • MBVD (Myocet+BVD)
  • Tricase, Lecce, Italy
  • +25 more
Aug 3, 2016

Her2 Positive Metastatic Breast Cancer Trial in Ireland (non-pegylated liposomal doxorubicon (Myocet™), Lapatinib (Tyverb™))

Terminated
  • Her2 Positive Metastatic Breast Cancer
  • non-pegylated liposomal doxorubicon (Myocet™)
  • Lapatinib (Tyverb™)
  • Cork, Ireland
  • +9 more
Oct 23, 2015

Breast Cancer Trial in Greece (Cyclophosphamide, Liposomal-encapsulated doxorubicin)

Terminated
  • Breast Cancer
  • Alexandroupolis, Greece
  • +10 more
Oct 6, 2015

Tubular Breast Cancer Stage II, Mucinous Breast Cancer Stage II, Breast Cancer Female NOS Trial in Fürstenwalde, Düsseldorf,

Completed
  • Tubular Breast Cancer Stage II
  • +7 more
  • Fürstenwalde, Brandenburg, Germany
  • +2 more
Feb 12, 2016

Breast Cancer, Tumor Metastasis Trial in Netherlands (Non pegylated liposomal doxorubicin and docetaxel)

Completed
  • Breast Cancer
  • Neoplasm Metastasis
  • Non pegylated liposomal doxorubicin and docetaxel
  • 's-Hertogenbosch, Netherlands
  • +9 more
Oct 5, 2015

Breast Cancer, Tumor Metastasis Trial in Netherlands (Non pegylated liposomal doxorubicin, trastuzumab, docetaxel)

Terminated
  • Breast Cancer
  • Neoplasm Metastasis
  • Non pegylated liposomal doxorubicin, trastuzumab, docetaxel
  • Arnhem, Netherlands
  • +6 more
Sep 22, 2015

Breast Cancer Trial in Madrid (trastuzumab, paclitaxel, Myocet)

Completed
Has Results
  • Breast Cancer
  • Madrid, Spain
    (unnamed)
Feb 26, 2015

Cerebral Lymphoma B Cell Refractory Trial in Brest, Paris, Rennes (infusion of MYOCET)

Terminated
  • Cerebral Lymphoma B Cell Refractory
  • infusion of MYOCET
  • Brest, France
  • +2 more
Jul 13, 2015